Suchergebnisse - "George, Aaron"

PubPharm (74)

1

Sleep bruxism : The past, the present, and the future-evolution of a concept

enthalten in: Journal of the American Dental Association (1939) | 2024

von Thomas, D. | Manfredini, D. | Patel, J. | +4

2

Vitamin C and Thiamin Deficiencies in Patients Undergoing Laparoscopic and Robotic Gastric Band Removal

enthalten in: The American surgeon | 2024

von Bonatti, H. | Frushour, C. | George, A.

3

Hypothyroidism Complicated by Vitamin C and Thiamin Deficiency in Surgical Patients

enthalten in: The American surgeon | 2023

von Bonatti, H. | Gona, S. | Feaga, C. | +1

4

Development and user testing study of MozzHub : a bipartite network-based dengue hotspot detector

enthalten in: Multimedia tools and applications | 2023

von Labadin, J. | Hong, B. | Tiong, W. | +13

5

Development and user testing study of MozzHub: a bipartite network-based dengue hotspot detector

enthalten in: Multimedia tools and applications | 2022

von Labadin, J. | Hong, B. | Tiong, W. | +13

6

Development and user testing study of MozzHub: a bipartite network-based dengue hotspot detector

enthalten in: Multimedia tools and applications | 2022

von Labadin, J. | Hong, B. | Tiong, W. | +13

7

Development and user testing study of MozzHub: a bipartite network-based dengue hotspot detector

enthalten in: Multimedia tools and applications | 2022

von Labadin, J. | Hong, B. | Tiong, W. | +13

8

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY) : a phase 3, randomised, controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Peyrin-Biroulet, L. | Hart, A. | Bossuyt, P. | +114

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):2-4. - PMID 34798035

9

Acute Cholecystitis in a Gastric Bypass Patient Complicated by Takotsubo Cardiomyopathy

enthalten in: Case reports in surgery | 2022

von Jawaid, M. | El-Sherif, T. | George, A. | +1

10

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS) : two phase 3 randomised, controlled trials

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Rubin, D. | Dotan, I. | DuVall, A. | +114

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):2-4. - PMID 34798035

1
2
3
4
5
6
7
8
Nächster »
[8]